Market Overview

Piper Jaffray Initiates Coverage on Orexigen Therapeutics, Inc. at Overweight, Announces $10.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for OREX

DateFirmActionFromTo
Oct 2013Cowen & CompanyInitiates Coverage onOutperform
Jan 2013Piper JaffrayInitiates Coverage onOverweight
Oct 2012Jefferies & CompanyMaintainsHold

View More Analyst Ratings for OREX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (OREX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional